The t(2;5) chromosomal translocation occurs in anaplastic large-cell lymphoma arising from activated T lymphocytes. This genomic rearrangement generates the nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) oncoprotein that is a chimeric protein consisting of parts of the nuclear protein NPM and ALK receptor proteintyrosine kinase. We used yeast two-hybrid screening to identify an adaptor protein Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target (SNT)-2 as a new partner that interacted with the cytoplasmic domain of ALK. Immunoprecipitation assay revealed that SNT-1 and SNT-2 interacted with NPM-ALK and kinasenegative NPM-ALK mutant. Y156, Y567 and a 19-amino-acid sequence (aa 631-649) of NPM-ALK were essential for this interaction. The interaction through Y156 and Y567 was dependent on phosphorylation of these tyrosines, whereas the interaction through the 19-amino-acid sequence was independent of phosphorylation. NPM-ALK mutant protein mutated at these three binding sites showed significantly reduced transforming activity. This transformation-defective NPM-ALK mutant still interacted with signal transducing proteins such as phospholipase C-gamma and phosphatidylinositol 3-kinase, which were previously reported to be relevant to NPM-ALK-dependent tumorigenesis. These observations indicate that the three SNT-binding sites of NPM-ALK are important for its transforming activity. This raises a possibility that SNT family proteins play significant roles in cellular transformation triggered by NPM-ALK, which though remains to be verified.
Anaplastic large-cell lymphoma (ALCL) constitutes non-Hodgkin's lymphoma subgroup that often expresses the membrane antigen CD30 (Herbst et al., 1991) . Most patients (75%) with this lymphoma display a specific chromosomal translocation t(2;5)(p23;q35) that fuses a part of the gene on chromosome 5 encoding the N-terminal proximal portion of nucleophosmin (NPM) with a part of the gene on chromosome 2 encoding the cytoplasmic domain of anaplastic lymphoma kinase (ALK) (Morris et al., 1994; Shiota et al., 1994) . The fusion protein NPM-ALK possesses constitutive tyrosine kinase activity and can transform NIH3T3 cells (Fujimoto et al., 1996) .
Previous studies have shown that (1) IRS-1 and Shc but not Grb2, are dispensable for NPM-ALK-mediated cell transformation (Fujimoto et al., 1996) ; (2) although NPM-ALK with Y664A mutation at the phospholipase C-gamma (PLC-g) binding site does not transform Ba/ F3 cells, truncated ALK proteins lacking amino acid 664 efficiently transform and Fischer rat 3T3 (Fr3T3) cells (Bai et al., 1998) ; (3) forced expression of ALK leads to phosphorylation of signal transducer and activator of transcription 3 (Zamo et al., 2002; Zhang et al., 2002) and activation of phosphatidylinositol 3-kinase (PI3K) (Slupianek et al., 2001) . However, the signaling mechanism downstream of NPM-ALK has not been well understood.
Suc1-associated neurotrophic factor-induced tyrosinephosphorylated target (SNT)-1/FRS2a and SNT-2/ FRS2b are related membrane-anchored docking proteins. SNT-1 plays a role in mediating signals from activated receptors, such as fibroblast growth factor receptor (FGFR) and TrkA (Hadari et al., 1998) . The PTB domain of SNT-1 binds to the NPXpY motif of TrkA upon activation in a phosphorylation-dependent manner (Meakin et al., 1999) and to FGFR1 constitutively in a phosphorylation-independent manner (Dhalluin et al., 2000; Ong et al., 2000) . The importance of FRS2b/SNT-2 in mediating FGF signal is shown using FRS2a À/À mice . To establish the mechanism by which NPM-ALK transforms cells, we searched for molecules that interacted with ALK by yeast two-hybrid screening. The bait was the cytoplasmic part (residues 133-680) of NPM-ALK ligated to the GAL4 DNA-binding domain that was shown to be autophosphorylated in yeast ( Figure 1a) . We screened B1.8 Â 10 7 yeast transformants containing a human fetal brain cDNA library and isolated candidate cDNA clones. These cDNA clones contained an entire open reading frame (ORF) of either Shc or SNT-2. To determine whether ALK interacts with SNT-2 in a phosphotyrosine-dependent manner, we performed b-galactosidase assay on colonies expressing SNT-2 or Shc. SNT-2 interacted not only with kinase-active ALK but also with kinase-negative ALK-KN, although this interaction was less efficient (Figure 1b) . In contrast, Shc interacted with only kinase-active ALK. We further investigated phosphotyrosine dependency of the interaction between NPM-ALK and SNT2 in mammalian cells. Co-immunoprecipitation assay using lysates of the transfectants confirmed that SNT-2 interacted with both NPM-ALK and NPM-ALK-KN (Figure 2a) . Therefore, it appeared that there were two modes of interaction between SNT-2 and NPM-ALK, phosphorylation-dependent and phosphorylation-independent modes. NPM-ALK binds through its NPXpY motifs to the PTB domains of IRS-1 and Shc at Y156 and Y567 (Fujimoto et al., 1996) . These motifs are also targets for 293T cells cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum were transfected with pcDNA3.1A (Invitrogen, Carlsbad, CA, USA) carrying myc-tagged SNT-2 (from M Goldfarb) together with or without pME18S that carries the Flag tagged NPM-ALK or NPM-ALK-KN. A Flag tag was linked at the N-terminus of NPM-ALK and NPM-ALK-KN. At 48 h after transfection, cells were washed with ice-cold phosphatebuffered saline (PBS) and lysed in TNE buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40, 2 mM EDTA) containing 1 mM sodium orthovanadate, 100 U/ml aprotinin and 2 mM phenylmethylsulfonyl fluoride. The interaction between NPM-ALK or its kinase-negative mutant and SNT-2 was analysed by immunoprecipitation (IP) of the lysates with anti-Flag (Sigma, St Louis, MO, USA) followed by immunoblotting (IB) with anti-myc (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or by IP of the lysates with anti-myc followed by IB with anti-Flag. Proteins in the total cell lysates (TCL) were blotted with anti-Flag and anti-myc antibodies. (b-e) 293T cells were transfected with vector expressing SNT-2 (b and d) or SNT-1 (c and e) either alone or together with each of the NPM-ALK mutants. Deletion mutants of NPM-ALK were constructed by PCR-based methods. pME18S-Flag-NPM-ALK-2F (2F: Y156/567F mutation) was constructed from pME18S-NPM-ALK-2F (Fujimoto et al., 1996) . For introducing D631-680 and D651-680 deletions in expression vectors, the nucleotides encoding, respectively, the C-terminal 50 and 30 amino acids of the NPM-ALK or NPM-ALK-2F were removed and a stop codon was inserted. For pME18S-Flag-NPM-ALK-2F D631-649, aminoacids residues 631-649 of NPM-ALK-2F were deleted. The lysate was immunoprecipitated with anti-Flag or anti-SNT-2 antibodies followed by SDS-PAGE and IB with anti-Flag and anti-SNT-2 (b and d) or anti-SNT-1 (Santa Cruz Biotechnology) (c and e) antibodies as indicated. The rabbit polyclonal antibodies against SNT-2 were raised against a synthesized peptide (residues 293-311 of SNT-2).
SNT binding to NPM-ALK oncoprotein M Chikamori et al the PTB domain of SNT-2 (Kurokawa et al., 2001) . To determine auto-phosphorylation-independent SNT binding sites, we constructed NPM-ALK-KN plasmids carrying various deletions from the C-terminus and transfected them to 293T cells. Co-immunoprecipitation assay revealed that the residues 631-680 in NPM-ALK bind to SNT-2 in a manner independent of autophosphorylation (Figure 2a and b) . We also found that SNT-2 bound a series of NPM-ALK deletion constructs deleted from C-terminus up to the residue at 459. Importantly, when the deletion extends further upstream of amino-acid position 567, NPM-ALK with Y156F mutation did not bind to SNT-2 (unpublished data). Then, we transfected cells with the plasmid encoding NPM-ALK mutant containing Tyr to Phe substitutions at amino acids 156 and 567 (Y156/567F or 2F), a C-terminal deletion (D631-680) or both (2F D631-680). Co-immunoprecipitation experiments revealed that SNT-2 interacted with the 2F and D631-680 mutants to similar extents as with NPM-ALK, but SNT-2 did not interact with NPM-ALK-2F D631-680. Because SNT-2 interacts with NPM-ALK-2F D650-680 mutant (Figure 2b ), the 19 amino-acid sequence (aa 631-649) was suggested to be responsible for the phosphotyrosine-independent binding of SNT-2. We also showed that SNT-1 bound to NPM-ALK with virtually the same binding characteristics as SNT-2 (Figure 2c ). Furthermore, we confirmed that NPM-ALK-2F D631-649 did not bind to SNT proteins (Figure 2d and e) . Thus, we tentatively concluded that Y156, Y567 and amino acids at 631-649 of NPM-ALK were binding sites for SNT proteins serving for phosphotyrosine-dependent (Y156 and Y567) and -independent (the 19 amino acids at 631-649) binding.
To address the role of SNT proteins in the NPM-ALK-mediated oncogenic signaling, we tested the oncogenicity of NPM-ALK and its mutants that either bound or did not bind to SNT proteins. As shown in Figure 3a and b, NPM-ALK-2F D631-649 showed very poor transforming activity, whereas the 2F and D631-649 mutants showed about 50-100% transforming activity of NPM-ALK. We also showed that the cell lines expressing NPM-ALK, NPM-ALK-2F and NPM-ALK D631-649 showed morphologies characteristic of transformed cells. In contrast, the cell lines expressing NPM-ALK-KN and NPM-ALK-2F D631-649 showed no morphologically transformed appearance (Figure 3c ). Therefore, we concluded that kinase activity and the SNT-binding sites of NPM-ALK are critical for its transforming activity. Consistently, we showed NPM-ALK-KN had little transforming activity in the focus formation assay (focus forming abilities of vector plasmid, NPM-ALK and NPM-ALK-KN were 1, 135 and 10 per mg DNA, respectively).
SNT-1 and Shc compete for binding with TrkA, and this competition might act as a switch between cell cycle progression and cell cycle arrest/differentiation (Meakin et al., 1999) . SNT proteins would also be in competition with IRS-1 and Shc for binding to Y156 and Y567 of NPM-ALK. It should be noted that the transforming ability of NPM-ALK through Y156 and Y567, which involves not only SNTs but also Shc and IRS-1, is more effective than that through 631-649, which involves only SNTs. Therefore, transforming signals downstream of Shc and IRS-1 are thought to be more rigorous than those downstream of SNTs. Signalings through different adaptor proteins may confer various distinct roles on SNT binding to NPM-ALK oncoprotein M Chikamori et al ALK in physiological conditions. Further experimental data are needed to establish this notion. There are reports that PLC-g and Phosphatidylinositol 3-kinase are essential for NPM-ALK-mediated transformation of ALCL cells (Bai et al., 1998 (Bai et al., , 2000 . We therefore examined whether the NPM-ALK-2F D631-649 mutant protein interacted with PLC-g and PI3K. As shown in Figure 3d and e, we found that PLCg and PI3K bound to the mutant protein. In addition, we found that NPM-ALK D631-680 bound to PLC-g (Figure 3e, lane 4) . This contradicts previous findings that PLC-g bound to NPM-ALK through phosphorylated Y664 (Bai et al., 1998) . We do not have proper explanation for the apparent discrepancy except to state that PLC-g can bind to NPM-ALK at site(s) other than phosphorylated Y664. Our present observations argue that binding of PLC-g and PI3K to NPM-ALK is not necessarily relevant to NPM-ALK-mediated transformation.
Recent evidence suggests that SNT proteins play roles as negative regulators of fibroblast growth factor (FGF) and epidermal growth factor (EGF) signaling in distinct mechanisms (Lax et al., 2002; Huang et al., 2004) . For example, SNT-1 becomes threonine phosphorylated by mitogen-activated protein kinase (MAPK) upon FGF stimulation and that MAPK-phosphorylated SNT-1 is utilized in negative feedback mechanism for FGF signaling (Lax et al., 2002) . Another report showed that SNT-2, when unphosphorylated, interacts with Erk1/2 and that the association is augmented in EGF stimulated cells, and that the association results in suppression of Erk signaling (Huang et al., 2004) . It should be noted, however, that tyrosine phosphorylation of SNT-1 and SNT-2, which has been shown to occur upon FGF and NGF stimulation but not upon EGF and PDGF stimulation, is important for positive signaling mechanisms (Kao et al., 2001) . SNT-1/2 becomes tyrosine phosphorylated and interacts with NPM-ALK. It is thus expected that NPM-ALK utilizes SNT-1/2 for positive signaling. We do not exclude the possibility that SNT-1 functions in the MAPK-mediated negative feedback mechanism in NPM-ALK signaling.
Our findings led us to speculate that SNT proteins may function in normal ALK-mediated signaling, which, however, needs to be experimentally demonstrated. Although biological roles of normal ALK remain elusive, the expression pattern of Alk mRNA (Iwahara et al., 1997; Morris et al., 1997) suggests that ALK plays roles in the central nervous system. Both Snt-1 and Snt-2 mRNAs are expressed in the brain (McDougall et al., 2001) , supporting the idea that SNT proteins function downstream of ALK in the brain.
